e 4031 has been researched along with tamoxifen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sen, S; Sinha, N | 1 |
| Ebert, SN; Katchman, A; Liu, XK; Woosley, RL | 1 |
| Lu, JY; Wu, BW; Wu, DM | 1 |
3 other study(ies) available for e 4031 and tamoxifen
| Article | Year |
|---|---|
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
The antiestrogen tamoxifen blocks the delayed rectifier potassium current, IKr, in rabbit ventricular myocytes.
Topics: Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Estrogen Antagonists; Heart Ventricles; Myocardium; Patch-Clamp Techniques; Piperidines; Potassium; Potassium Channels; Pyridines; Rabbits; Tamoxifen; Time Factors; Torsades de Pointes | 1998 |
Class III anti-arrhythmia drug E-4031 potentiates Na+/Ca2+ exchange current in rat ventricular myocytes.
Topics: Animals; Anti-Arrhythmia Agents; Cell Separation; Heart Ventricles; Myocardium; Piperidines; Protein Kinase C; Pyridines; Rats; Sodium-Calcium Exchanger; Tamoxifen; Tetradecanoylphorbol Acetate | 2000 |